Rapamycin Protects against Neuron Death in In Vitro andIn Vivo Models of Parkinson's Disease
暂无分享,去创建一个
Lloyd A Greene | L. Greene | S. Przedborski | V. Jackson-Lewis | Serge Przedborski | C. Malagelada | Vernice Jackson-Lewis | Cristina Malagelada | Zong Hao Jin | Z. Jin
[1] A. Marette,et al. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. , 2005, Endocrinology.
[2] P. Bain. CHANGING CONCEPTS IN PARKINSON DISEASE: MOVING BEYOND THE DECADE OF THE BRAIN , 2009, Neurology.
[3] Wolfgang Arnold,et al. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase , 2005, Oncogene.
[4] S. Kish,et al. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining , 1997, Neuroscience.
[5] Wenhua Zheng,et al. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling , 2002, Journal of neurochemistry.
[6] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[7] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[8] Jiang-Ning Zhou,et al. Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells. , 2008, Cellular signalling.
[9] L. Greene,et al. Death in the Balance: Alternative Participation of the Caspase-2 and -9 Pathways in Neuronal Death Induced by Nerve Growth Factor Deprivation , 2001, The Journal of Neuroscience.
[10] J. Olefsky,et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.
[11] F. Zhong,et al. Dexamethasone-induced Gene 2 (dig2) Is a Novel Pro-survival Stress Gene Induced Rapidly by Diverse Apoptotic Signals* , 2003, Journal of Biological Chemistry.
[12] O. Isacson,et al. Immunophilin Ligands and GDNF Enhance Neurite Branching or Elongation from Developing Dopamine Neurons in Culture , 2000, Experimental Neurology.
[13] K. Pong,et al. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. , 2003, Current drug targets. CNS and neurological disorders.
[14] David Park,et al. Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.
[15] R. Abraham,et al. Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.
[16] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[17] L. Swiech,et al. Role of mTOR in physiology and pathology of the nervous system. , 2008, Biochimica et biophysica acta.
[18] L. Helman,et al. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism , 2007, Oncogene.
[19] Dena Leshkowitz,et al. Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis , 2002, Molecular and Cellular Biology.
[20] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[21] Wei Zhang,et al. Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.
[22] R. Burke,et al. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease , 2006, Proceedings of the National Academy of Sciences.
[23] Lloyd A Greene,et al. Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cellular Models of Parkinson's Disease , 2002, The Journal of Neuroscience.
[24] Simon C Watkins,et al. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.
[25] S. Korsmeyer,et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Snyder,et al. Neural actions of immunophilin ligands. , 1998, Trends in pharmacological sciences.
[27] Lewis C Cantley,et al. PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.
[28] Satoshi Orimo,et al. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease , 2008 .
[29] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[30] J. Heitman,et al. TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin (*) , 1995, The Journal of Biological Chemistry.
[31] C. Thompson,et al. Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. , 2003, Cancer research.
[32] Karen Lipkow,et al. Amelioration of protein misfolding disease by rapamycin: Translation or autophagy? , 2008, Autophagy.
[33] C. Achim,et al. Immunophilins and their ligands: insights into survival and growth of human neurons , 2002, Physiology & Behavior.
[34] P. Crino,et al. Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons , 2007, Epilepsy Research.
[35] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[36] C. Johannessen,et al. Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1 , 2005, Molecular and Cellular Biology.
[37] Francesco Scaravilli,et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.
[38] D. Rubinsztein,et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies , 2009, Cell Death and Differentiation.
[39] References , 1971 .
[40] A. Nairn,et al. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Kakita,et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. , 2008, Brain : a journal of neurology.
[42] L. Greene,et al. Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps , 2009, Apoptosis.
[43] J. Blenis,et al. Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy , 2009, Cell cycle.
[44] Sang Gyun Kim,et al. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation , 2008, Proceedings of the National Academy of Sciences.
[45] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[46] Geoffrey M Cooper,et al. Role of mTOR in the degradation of IRS‐1: Regulation of PP2A activity , 2002, Journal of cellular biochemistry.
[47] D. Sgroi,et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.
[48] S. Kimball,et al. Rapid Turnover of the mTOR Complex 1 (mTORC1) Repressor REDD1 and Activation of mTORC1 Signaling following Inhibition of Protein Synthesis* , 2008, Journal of Biological Chemistry.
[49] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[50] S. Snyder,et al. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] Y. Agid,et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.
[52] A. Yang,et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. , 2002, Molecular cell.
[53] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[54] Lloyd A Greene,et al. RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation , 2006, The Journal of Neuroscience.
[55] L. Greene,et al. Analysis of gene expression changes in a cellular model of Parkinson disease , 2005, Neurobiology of Disease.
[56] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[57] L. Greene,et al. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[59] R. Burke,et al. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[60] David R. Kaplan,et al. Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.
[61] L. Greene,et al. PC12 Cells as a model for parkinson's disease research , 2008 .
[62] D. Rubinsztein,et al. Rapamycin pre-treatment protects against apoptosis. , 2006, Human molecular genetics.
[63] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[64] Robert T. Abraham,et al. Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase* , 2005, Journal of Biological Chemistry.
[65] P. Castaigne,et al. [Medical treatment of Parkinson's disease]. , 1972, Annales de medecine interne.
[66] L. Greene,et al. RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation , 2008, The Journal of Neuroscience.
[67] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[68] B. Manning,et al. A complex interplay between Akt, TSC2 and the two mTOR complexes. , 2009, Biochemical Society transactions.
[69] D. Rubinsztein,et al. Small molecule enhancers of autophagy for neurodegenerative diseases. , 2008, Molecular bioSystems.